Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 3Phase 1/2 1

Status

Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Neoplasm Metastasis 11Carcinoma, Hepatocellular 7Colorectal Neoplasms 6Liver Neoplasms 5Rectal Neoplasms 4Colonic Neoplasms 4Pancreatic Neoplasms 3Lung Neoplasms 3Kidney Neoplasms 3Breast Neoplasms 3Pain 2Cholangiocarcinoma 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Thymoma 1Small Cell Lung Carcinoma 1Sarcoma 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasms 1Multiple Advanced Tumors After PD-1 Therapy Failure 1Mesothelioma, Malignant 1Jaundice, Obstructive 1Diabetes Mellitus, Insulin-Dependent, 12 1Colorectal Cancer Liver Metastases 1Biliary Tract Neoplasms 1Bile Duct Neoplasms 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

Trastuzumab 304Paclitaxel 257Cyclophosphamide 251Docetaxel 238Capecitabine 176Letrozole 163Carboplatin 163Fulvestrant 145Doxorubicin 145Bevacizumab 121Anastrozole 106Tamoxifen 102exemestane 94Vinorelbine 91Epirubicin 90pertuzumab 89Gemcitabine 84Lapatinib 80Albumin-Bound Paclitaxel 74Radiotherapy 71pembrolizumab 70palbociclib 64130-nm albumin-bound paclitaxel 58eribulin 56Cisplatin 55Everolimus 49pyrotinib 45Taxes 44Goserelin 43Neoadjuvant Therapy 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Breast Neoplasms × Radiofrequency Ablation × Clear all
NCT04698252 2022-08-08

LARA

Instituto do Cancer do Estado de São Paulo

Phase 2 Recruiting
74 enrolled
Breast

Breast Neoplasms

NCT03750396 2019-02-15

CLEAR

Gangnam Severance Hospital

Phase 2 Unknown
110 enrolled
Breast

Breast Neoplasms

NCT00373152 2017-12-05

MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer

Masonic Cancer Center, University of Minnesota

Phase 2 Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡